openPR Logo
Press release

Renal Denervation Devices Global Market is Anticipated to Hit $1.73 Billion By 2028, Owing to Rise in Incidences of Influenza Across the Globe

04-29-2024 12:59 PM CET | Health & Medicine

Press release from: The Business research company

Renal Denervation Devices Global Market

Renal Denervation Devices Global Market

The renal denervation devices market size has grown exponentially in recent years. It will grow from $0.42 billion in 2023 to $0.57 billion in 2024 at a compound annual growth rate (CAGR) of 35.1%. The growth in the historic period can be attributed to increased hypertension cases, clinical research and studies, increased in cardiovascular diseases, initial fda approval and regulatory developments, market entry of renal denervation systems.

The renal denervation devices market size is expected to see exponential growth in the next few years. It will grow to $1.73 billion in 2028 at a compound annual growth rate (CAGR) of 32.3%. The growth in the forecast period can be attributed to patient-centric approach, healthcare infrastructure development, growing awareness and acceptance, focus on minimally invasive therapies, market entry of new devices. Major trends in the forecast period include integration of artificial intelligence (ai) and machine learning, regulatory landscape changes, shift towards minimally invasive procedures, emphasis on clinical evidence, remote monitoring and telehealth integration.

Market Overview -
Renal denervation devices are minimally invasive medical devices used to treat hypertension (high blood pressure) that have not improved with other treatments. A catheter is passed into the renal arteries that ablate sympathetic nerves in the vessel wall using radiofrequency energy to allow greater blood flow to the kidneys.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10631&type=smp

The Surge In Renal Denervation Devices Market Fueled By Escalating Hypertension Rates
Increased prevalence of hypertension is expected to drive the growth of the renal denervation devices market growing forward. Hypertension, also known as high blood pressure, is a condition in which the force of blood flowing through the blood vessels is consistently too high. Renal denervation is a catheter-based procedure that has emerged as a potential therapeutic option for patients with resistant hypertension. Renal denervation is a minimally invasive, investigational procedure to treat hypertension that hasn't responded to medication. For instance, in January 2023, according to a report published by the Mississippi State Department of Health, a US-based Mississippi state health agency, nearly 1 million adult Mississippians (43.9%) had high blood pressure as of the year 2021. In 2021, MS had a prevalence of hypertension that was 36.3% higher than the US average (MS: 43.9%, US: 32.2%). Therefore, the increased prevalence of hypertension will promote the growth of the renal denervation devices market.

Competitive Landscape -
Major companies operating in the renal denervation devices market report are Boston Scientific Corporation, CardioSonic Ltd., Kona Medical Inc., Medtronic plc, Mercator MedSystems Inc., ReCor Medical, Abbott Laboratories, Ablative Solutions Inc., Terumo Corporation, Symple Surgical Inc., St. Jude Medical Inc., Johnson & Johnson Services Inc., Theragenics Corporation, Vascular Dynamics Inc., Otsuka Holdings Co. Ltd., Cardiovascular Systems Inc., Celonova Biosciences Inc., Concept Medical Inc., Cook Medical LLC, Cardinal Health Inc., Creganna Medical, Endologix Inc., Endospan Ltd., Enopace Biomedical Ltd., InspireMD Inc., MicroPort Scientific Corporation, Miracor Medical Systems GmbH, Nexeon MedSystems Inc., Asahi Kasei Corporation, Thermocool Limited

Renal Denervation Devices Market Surges With Cutting-Edge Product Developments
Product innovation is a key trend gaining popularity in the renal denervation devices market. Major companies operating in the renal denervation devices market are focused on developing innovative products to strengthen their position and gain a competitive advantage. For instance, in October 2021, ReCor Medical Inc., a US-based medical device company launched Paradise Ultrasound Renal Denervation System for hypertension treatment. This system is a minimally invasive procedure that uses non-focused ultrasound to treat overactive nerves leading to the kidney. The Paradise System has been shown to successfully reduce blood pressure compared to a sham procedure.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/renal-denervation-devices-global-market-report

Key Segments -
The renal denervation devices market covered in this report is segmented -
1) By Product: Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, Other Products
2) By Technology: Radio Frequency Ablation, Ultrasound Energy-Based RDN, Brachytherapy, Chemical Ablation, Other Technologies
3) By End-Users: Hospitals, Cardiovascular research centre, Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Renal Denervation Devices Global Market is Anticipated to Hit $1.73 Billion By 2028, Owing to Rise in Incidences of Influenza Across the Globe here

News-ID: 3479023 • Views:

More Releases from The Business research company

Veterinary Healthcare Global Market Analysis, Trends, Growth, Research And Forecast 2033
Veterinary Healthcare Global Market Analysis, Trends, Growth, Research And Forec …
The veterinary healthcare market size has grown strongly in recent years. It will grow from $192.55 billion in 2023 to $206.49 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to the increase in pet ownership, zoonotic diseases, livestock industry growth, regulatory compliance, . The veterinary healthcare market size is expected to see strong growth in the
Tumor Embolization Devices Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033
Tumor Embolization Devices Market 2024 Report By Key Companies, Regional Analysi …
The tumor embolization devices market size has grown rapidly in recent years. It will grow from $1.62 billion in 2023 to $1.82 billion in 2024 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to minimally invasive procedures, technological advancements, cancer incidence, aging population. The tumor embolization devices market size is expected to see rapid growth in the next few
Tea Capsule Market Trends, Top Companies, Share, Growth And Forecast 2033
Tea Capsule Market Trends, Top Companies, Share, Growth And Forecast 2033
The tea capsule market size has grown rapidly in recent years. It will grow from $1.28 billion in 2023 to $1.51 billion in 2024 at a compound annual growth rate (CAGR) of 17.4%. The growth in the historic period can be attributed to convenience and portability, sustainability, e-commerce growth. The tea capsule market size is expected to see rapid growth in the next few years. It will grow to
Stamped Metal Global Market Analysis, Trends, Growth, Research And Forecast 2033
Stamped Metal Global Market Analysis, Trends, Growth, Research And Forecast 2033
The stamped metal market size has grown strongly in recent years. It will grow from $464.27 billion in 2023 to $498.39 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to industrialization and manufacturing growth, automotive industry expansion, advancements in stamping technology, world wars and defense needs, urbanization and construction. The stamped metal market size is expected

All 5 Releases


More Releases for Renal

Renal Biomarker Market to register a CAGR of 7.0% by 2026: Rising Prevalence of …
Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period
Acute Renal Failure Epidemiology Insights to 2025
Publisher " Acute Renal Failure ARF Acute Kidney Injury - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Acute Renal Failure ARF Acute Kidney Injury in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Acute Renal Failure ARF Acute Kidney Injury prevalent or incident cases segmented by age, sex and subpopulations. The Report
Renal Insufficiency Market Vendor Growth Landscape 2025
Global Renal Insufficiency Market: Snapshot The demand for renal disease treatment products and therapies has been incrementing steadily in the past few years, owing to the prevalence of poor kidney functions among a vast population base across the world, especially in the Asia Pacific region, and increased government support. However, the participants of the global renal insufficiency market must take a note of weak competition among the marketed products for the
Acute Renal Failure - Pipeline Review, H1 2018
"The Report Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Acute Renal Failure Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury)
Acute Renal Failure Epidemiology Insights to 2025
Publisher " Acute Renal Failure ARF Acute Kidney Injury - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Acute Renal Failure ARF Acute Kidney Injury in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Acute Renal Failure ARF Acute Kidney Injury prevalent or incident cases segmented by age, sex and subpopulations. The Report
Renal Cluster Drug Development Pipeline Review, 2017
ReportsWorldwide has announced the addition of a new report title Renal Cluster Drug Development Pipeline Review, 2017 to its growing collection of premium market research reports. This report provides an overview of the renal cluster pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Kidney Fibrosis, Chronic Kidney Disease (Chronic Renal Failure), Acute Renal Failure (ARF), Kidney Transplant Rejection, and